0 Avaliações

ID

16259

Descrição

Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193076

Link

https://clinicaltrials.gov/show/NCT00193076

Palavras-chave

  1. 08/07/2016 08/07/2016 -
Transferido a

8 de julho de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility Breast Cancer NCT00193076

    Eligibility Breast Cancer NCT00193076

    Inclusion Criteria
    Descrição

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    to be included in this study, you must meet the following criteria:
    Descrição

    ID.1

    Tipo de dados

    boolean

    locally advanced or metastatic breast cancer
    Descrição

    Locally advanced breast cancer | Carcinoma breast stage IV

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C3495949
    UMLS CUI [2]
    C0278488
    measurable disease as per recist criteria
    Descrição

    Measurable Disease

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    no prior chemotherapy in the metastatic breast setting
    Descrição

    Prior Chemotherapy Carcinoma breast stage IV

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C1514457
    UMLS CUI [1,2]
    C0278488
    prior chemotherapy and/or hormonal therapy for early stage breast cancer
    Descrição

    Prior Chemotherapy Early-Stage Breast Carcinoma | Hormone Therapy Early-Stage Breast Carcinoma

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C1514457
    UMLS CUI [1,2]
    C2986665
    UMLS CUI [2,1]
    C0279025
    UMLS CUI [2,2]
    C2986665
    adjuvant herceptin is allowed
    Descrição

    Herceptin Adjuvant

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0338204
    UMLS CUI [1,2]
    C1522673
    prior radiation therapy in either the metastatic or early stage setting
    Descrição

    prior radiation therapy Carcinoma breast stage IV | prior radiation therapy Early-Stage Breast Carcinoma

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0279134
    UMLS CUI [1,2]
    C0278488
    UMLS CUI [2,1]
    C0279134
    UMLS CUI [2,2]
    C2986665
    patients may have received any number of hormonal therapies
    Descrição

    Hormone Therapy Quantity

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0279025
    UMLS CUI [1,2]
    C1265611
    age >18 years
    Descrição

    Age

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    only women are eligible for the study
    Descrição

    Gender

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    able to perform activities of daily living with minimal assistance
    Descrição

    Performance of activities of daily living Ability | Assistance Minimal

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C1821398
    UMLS CUI [1,2]
    C0085732
    UMLS CUI [2,1]
    C0557034
    UMLS CUI [2,2]
    C0547040
    normal organ and bone marrow function
    Descrição

    organ function | Bone Marrow function

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0678852
    UMLS CUI [2,1]
    C0005953
    UMLS CUI [2,2]
    C0031843
    patients who will be receiving trastuzumab must have normal heart function
    Descrição

    trastuzumab | Cardiac function

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0728747
    UMLS CUI [2]
    C0232164
    sign a written informed consent document
    Descrição

    Informed consent

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Descrição

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    you cannot participate in this study if any of the following apply to you:
    Descrição

    Study Subject Participation Status

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    received prior chemotherapy for metastatic breast cancer
    Descrição

    Prior Chemotherapy Carcinoma breast stage IV

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C1514457
    UMLS CUI [1,2]
    C0278488
    known leptomeningeal carcinomatosis
    Descrição

    Leptomeningeal Carcinomatosis

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0220654
    uncontrolled brain metastasis
    Descrição

    Metastatic malignant neoplasm to brain Uncontrolled

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0220650
    UMLS CUI [1,2]
    C0205318
    uncontrolled intercurrent illness
    Descrição

    Intercurrent disease Uncontrolled

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0277557
    UMLS CUI [1,2]
    C0205318
    pregnant or lactating
    Descrição

    Pregnancy | Breast Feeding

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    history of other non-breast cancer malignancy
    Descrição

    Malignant Neoplasms | Breast Carcinoma

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    UMLS CUI [2]
    C0678222
    received prior chemotherapy for early stage breast cancer within 6 months
    Descrição

    Prior Chemotherapy Early-Stage Breast Carcinoma

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C1514457
    UMLS CUI [1,2]
    C2986665
    please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
    Descrição

    criteria Additional | Study Subject Participation Status

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0243161
    UMLS CUI [1,2]
    C1524062
    UMLS CUI [2]
    C2348568

    Similar models

    Eligibility Breast Cancer NCT00193076

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    to be included in this study, you must meet the following criteria:
    boolean
    Locally advanced breast cancer | Carcinoma breast stage IV
    Item
    locally advanced or metastatic breast cancer
    boolean
    C3495949 (UMLS CUI [1])
    C0278488 (UMLS CUI [2])
    Measurable Disease
    Item
    measurable disease as per recist criteria
    boolean
    C1513041 (UMLS CUI [1])
    Prior Chemotherapy Carcinoma breast stage IV
    Item
    no prior chemotherapy in the metastatic breast setting
    boolean
    C1514457 (UMLS CUI [1,1])
    C0278488 (UMLS CUI [1,2])
    Prior Chemotherapy Early-Stage Breast Carcinoma | Hormone Therapy Early-Stage Breast Carcinoma
    Item
    prior chemotherapy and/or hormonal therapy for early stage breast cancer
    boolean
    C1514457 (UMLS CUI [1,1])
    C2986665 (UMLS CUI [1,2])
    C0279025 (UMLS CUI [2,1])
    C2986665 (UMLS CUI [2,2])
    Herceptin Adjuvant
    Item
    adjuvant herceptin is allowed
    boolean
    C0338204 (UMLS CUI [1,1])
    C1522673 (UMLS CUI [1,2])
    prior radiation therapy Carcinoma breast stage IV | prior radiation therapy Early-Stage Breast Carcinoma
    Item
    prior radiation therapy in either the metastatic or early stage setting
    boolean
    C0279134 (UMLS CUI [1,1])
    C0278488 (UMLS CUI [1,2])
    C0279134 (UMLS CUI [2,1])
    C2986665 (UMLS CUI [2,2])
    Hormone Therapy Quantity
    Item
    patients may have received any number of hormonal therapies
    boolean
    C0279025 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    Age
    Item
    age >18 years
    boolean
    C0001779 (UMLS CUI [1])
    Gender
    Item
    only women are eligible for the study
    boolean
    C0079399 (UMLS CUI [1])
    Performance of activities of daily living Ability | Assistance Minimal
    Item
    able to perform activities of daily living with minimal assistance
    boolean
    C1821398 (UMLS CUI [1,1])
    C0085732 (UMLS CUI [1,2])
    C0557034 (UMLS CUI [2,1])
    C0547040 (UMLS CUI [2,2])
    organ function | Bone Marrow function
    Item
    normal organ and bone marrow function
    boolean
    C0678852 (UMLS CUI [1])
    C0005953 (UMLS CUI [2,1])
    C0031843 (UMLS CUI [2,2])
    trastuzumab | Cardiac function
    Item
    patients who will be receiving trastuzumab must have normal heart function
    boolean
    C0728747 (UMLS CUI [1])
    C0232164 (UMLS CUI [2])
    Informed consent
    Item
    sign a written informed consent document
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Study Subject Participation Status
    Item
    you cannot participate in this study if any of the following apply to you:
    boolean
    C2348568 (UMLS CUI [1])
    Prior Chemotherapy Carcinoma breast stage IV
    Item
    received prior chemotherapy for metastatic breast cancer
    boolean
    C1514457 (UMLS CUI [1,1])
    C0278488 (UMLS CUI [1,2])
    Leptomeningeal Carcinomatosis
    Item
    known leptomeningeal carcinomatosis
    boolean
    C0220654 (UMLS CUI [1])
    Metastatic malignant neoplasm to brain Uncontrolled
    Item
    uncontrolled brain metastasis
    boolean
    C0220650 (UMLS CUI [1,1])
    C0205318 (UMLS CUI [1,2])
    Intercurrent disease Uncontrolled
    Item
    uncontrolled intercurrent illness
    boolean
    C0277557 (UMLS CUI [1,1])
    C0205318 (UMLS CUI [1,2])
    Pregnancy | Breast Feeding
    Item
    pregnant or lactating
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Malignant Neoplasms | Breast Carcinoma
    Item
    history of other non-breast cancer malignancy
    boolean
    C0006826 (UMLS CUI [1])
    C0678222 (UMLS CUI [2])
    Prior Chemotherapy Early-Stage Breast Carcinoma
    Item
    received prior chemotherapy for early stage breast cancer within 6 months
    boolean
    C1514457 (UMLS CUI [1,1])
    C2986665 (UMLS CUI [1,2])
    criteria Additional | Study Subject Participation Status
    Item
    please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
    boolean
    C0243161 (UMLS CUI [1,1])
    C1524062 (UMLS CUI [1,2])
    C2348568 (UMLS CUI [2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial